Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Our Work > Events > 2016 Assessing Global Health Security

Assessing Countries' Global Health Security Capabilities

An International Public Health Symposium Convened by the UPMC Center for Health Security

Speaker Biographies

October 19, 2016
W Hotel, Washington, DC

Crystal BODDIE, MPH | Jose FERNANDEZ, PhD | Thomas M. GOMEZ, DVM, MS | Li-Li HO, MPH | Kashef IJAZ, MD, MPH | Tom INGLESBY, MD | Shu-Wan JIAN, DVM, MPH | Hui-Yun KAO, MSc | William B. KARESH, DVM | Lawrence D. KERR, PhD | Nai-Wen KUO, PhD, MPH | Steve Hsu-Sung KUO, MD, MPH, PHD | Philip Yi-Chun LO, MD | Maria Julia MARINISSEN, PhD | Jennifer NUZZO, DrPH | Theresa L. SMITH, MD, MPH | Eric TONER, MD | Ji-Rong YANG, MSc



Crystal Boddie is a senior associate at the UPMC Center for Health Security. Her policy research focuses on public health risk assessment, public health and healthcare preparedness and response, biodefense, and emerging infectious diseases. She also conducts research on the funding and management of biodefense and health security in the US federal government. Ms. Boddie is the Program Manager for the Center’s Emerging Leaders in Biosecurity program (ELBI),

From 2012 to 2013, Ms. Boddie served as program manager for the Integrated (CBRN) Terrorism Risk Assessment (ITRA) program of the US Department of Homeland Security (DHS), Science and Technology Directorate. The ITRA program is mandated by presidential directive and is linked to decision making in a number of parts of the US government, including the Department of Health and Human Services (HHS), the DoD, the intelligence community, and the Environmental Protection Agency, among others.

During her year as ITRA program manager, Ms. Boddie also coordinated and supported a joint DHS/HHS study to inform the contents of the US Centers for Disease Control and Prevention’s (CDC) Strategic National Stockpile (SNS). In addition, she led an assessment of the chemical, biological, radiological, and explosives risk to the DHS mail stream and screening facility.

Since joining the Center in 2004, Ms. Boddie has authored a number of peer-reviewed articles and reports on issues including federal decontamination plans for a wide-area biological attack; federal, state, and local medical response to Hurricane Katrina; and the National Hospital Preparedness Program. She serves as an associate editor of the journal Health Security (formerly Biosecurity and Bioterrorism).

Ms. Boddie is a DrPH candidate at the Johns Hopkins Bloomberg School of Public Health (JHSPH) in the Department of Health Policy and Management, focusing on public health management and risk assessment. Ms. Boddie received her MPH degree from JHSPH in May 2009, and she earned her BA in molecular, cellular, and developmental biology in 2004 from the University of Colorado at Boulder.


Jose Fernandez serves as the Global Health Security Agenda (GHSA) team lead at the US Department of Health and Human Services (HHS), Office of Global Affairs (OGA), supporting this multilateral and multisectoral US government priority. His team plays a key role on behalf of HHS in conducting diplomatic outreach to increase awareness of and commitment to GHSA by key international partners; coordinates with US government interagency partners on diplomatic engagement, policy development, and strategic planning; and provides the primary US government interface with the GHSA Steering Group. From 2006 to 2007, Dr. Fernandez worked at HHS as a global security fellow co-sponsored by the American Association for the Advancement of Science and the Nuclear Threat Initiative. During this time, he led the US government's implementation of the International Health Regulations (IHR) in coordination with the White House Homeland and National Security Councils. Prior to his fellowship, Dr. Fernandez worked as a consultant on biological and small molecule databases. He has a BS in biology from Walsh College, an MS in biology from the University of Akron, and a PhD in biochemistry from Purdue University.


Thomas M. GOMEZ, DVM, MS

Tom Gomez is a veterinary medical staff officer with the USDA, APHIS, VS, SPRS, One Health Coordination Center staff in Atlanta, Georgia. He received his DVM and MS degrees from Colorado State University. He was also an Epidemic Intelligence Service (EIS) officer with the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. In his current position, Dr. Gomez serves as the APHIS/VS liaison to the CDC in Atlanta, where he facilitates collaboration, communication, and coordination between APHIS and CDC on issues of mutual agency interest.

Dr. Gomez was in private veterinary practice for 2 years before joining the USDA, APHIS, VS, where he worked as a field veterinary medical officer, NAHMS coordinator, staff veterinarian for the Salmonella Enteritidis Task Force, and senior staff veterinarian with the National Center for Animal Health Emergency Management.



Li-Li Ho is a senior technical specialist, Quarantine Division, Centers for Disease Control, Ministry of Health and Welfare, ROC (Taiwan). Prior to this, Ms. Ho was section chief, Office of Public Relations, and technical specialist, Division of Acute Infectious Diseases, both at the Taiwan CDC.

Ms. Ho has a master’s degree in public health policy and management, National Taiwan University College of Public Health, and a bachelor’s degree in public health from China Medical University, Taiwan.



Kashef IJAZ, MD, MPH

Kashef Ijaz is the principal deputy director for the Division of Global Health Protection in the Center for Global Health. The division includes some of CDC’s primary global health programs, such as Global Disease Detection, Field Epidemiology Training, Global Health Security, and humanitarian emergencies and recovery work. Dr. Ijaz is a member of division’s senior leadership and oversees the science and research agenda for the division, ensuring that the scientific projects, protocols, and epidemiologic investigations are conducted based on established scientific/epidemiologic methods. He also provides consultation and guidance on programmatic aspects to the branches in the division as well as the policy, communications, and partnerships offices in the division.

Previously, Dr. Ijaz was the deputy director for science and programs in the Division of Global Disease Detection and Emergency Response. In the recent past, he has served as the senior regional advisor for Field Epidemiology and Laboratory Training Program for the Middle East and North Africa Region in the Division of Public Health Systems and Workforce Development. During his tenure at CDC, he has also served the chief of the Outbreak Investigations team in the Division of Tuberculosis Elimination, and then as chief of the Field Services and Evaluation Branch in the Division of Tuberculosis Elimination. As the lead for the outbreak investigations team, he trained numerous Epidemic Intelligence Service officers and also responded to numerous TB outbreak investigations, both in the United States and internationally. In his appointment as the chief of the Field Services and Evaluation Branch, he led one of the largest branches (with a budget of over $100 million) at CDC, with staff of more than 70 people, including public health advisors, epidemiologists, and medical officers. He was responsible for the TB control activities in the entire United States and its territories (including funding support and technical assistance). He helped update a data-driven formula for funding of TB control programs in the country and developed the capacity to conduct program evaluation, including a program evaluation network to build evaluation capacity at state and local levels.

Prior to coming to CDC, Dr. Ijaz was the research assistant professor, Department of Internal Medicine, University of Arkansas for Medical Sciences in Little Rock. He is a physician trained in internal medicine and has a master’s degree in public health from the University of Oklahoma Health Sciences Center. He is also the adjunct associate professor in the Department of Epidemiology, Rollins School of

Public Health, Emory University. His research involves prevention and control of infectious diseases, molecular epidemiology, and genotyping of Mycobacterium tuberculosis. Dr. Ijaz has more than 40 publications in peer-reviewed journals and a book chapter.



Tom Inglesby is director of the UPMC Center for Health Security, a nongovernmental organization dedicated to protecting people’s health from the consequences of epidemics and disasters and to ensuring that communities are resilient to those challenges. He is an associate professor of medicine and public health at the University of Pittsburgh Schools of Medicine and Public Health.

Dr. Inglesby’s work is internationally recognized in the fields of public health preparedness, pandemic flu and epidemic planning, and biosecurity. He is chair of the Board of Scientific Counselors, Office of Public Health Preparedness and Response, US Centers for Disease Control and Prevention (CDC). He is chair of the National Advisory Council of the Robert Wood Johnson Foundation National Health Security Preparedness Index. He is a member of the External Laboratory Safety Workgroup appointed by the CDC director that is examining the biosafety practices of the CDC, the National Institutes of Health (NIH), and the Food and Drug Administration (FDA). He is on the Advisory Committee to the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary of Preparedness and Response of the Department of Health and Human Services. He has also served on committees of the Defense Science Board and the National Academies of Sciences and in an advisory capacity to DHS and DARPA.

During the past 15 years, Dr. Inglesby has authored or co-authored more than 90 peer-reviewed articles, reports, and editorials on a range of issues related to health and security. He is editor-in-chief of the journal Health Security, which he helped to establish 14 years ago as the first peer-reviewed journal in its field, under its original title, Biosecurity and Bioterrorism. He was a principal editor of the JAMA book Bioterrorism: Guidelines for Medical and Public Health Management. He has been invited to brief White House officials from the past 3 presidential administrations on national biosecurity challenges and priorities, and he has delivered congressional testimony on public health preparedness and biosecurity. He is regularly consulted by major news outlets for his expertise. He is also on the board of directors of PurThread, a company dedicated to developing antimicrobial textiles.

Dr. Inglesby completed his internal medicine and infectious diseases training at Johns Hopkins University School of Medicine, where he also served as assistant chief of service in 1996-97. Dr. Inglesby received his MD from Columbia University College of Physicians and Surgeons and his BA from Georgetown University. He continues to see patients in a weekly infectious disease clinic.



Shu-Wan Jian is an epidemiologist/technical specialist, Epidemic Intelligence Center, Centers for Disease Control, ROC (Taiwan).

Dr. Jian has a master’s of public health degree from the College of Public Health, National Taiwan University, Taiwan, and a doctor of veterinary medicine degree from National Taiwan University, Taiwan.


Hui-Yun KAO, MSc

Hui-Yun Kao is a junior public health policy officer, Division of Preparedness and Emerging Infectious Diseases, Taiwan Centers for Disease Control. Prior to this, Hui-Yun served as an administrative associate, First Division, Planning and International Affairs, Taiwan Centers for Disease Control.

Hui-Yun has a master of science in Global Health and Development, Institute for Global Health, University College, London, and a master of science in zoology (neurobiology) from National Taiwan University, Taipei, Taiwan.


William B. KARESH, DVM

William Karesh is the executive vice president for health and policy for EcoHealth Alliance. He serves as the inter-project liaison for the USAID Emerging Pandemic Threats PREDICT-2 program (a $140M effort to prevent infectious diseases in 30 countries) and is a member of World Health Organization’s IHR Roster of Experts. Dr. Karesh also serves as the president of the World Organization for Animal Health (OIE) Working Group on Wildlife. He was recently appointed as a member of the Council on Foreign Relations.

Dr. Karesh has pioneered initiatives focusing attention and resources on solving problems created by the interactions among wildlife, people, and their animals. He coined the term “One Health” to describe the interdependence of healthy ecosystems, animals, and people, and the term has been adopted by many organizations, including the United Nations, in local and global health efforts. Dr. Karesh has created dozens of initiatives to encourage linkages among public health, agriculture, and environmental health agencies and organizations around the world. He has personally led programs and projects in more than 45 countries, covering terrain from Argentina to Zambia.

In addition to his work in the private nonprofit sector, Dr. Karesh has also worked for the USDA, DOD and DOI. He serves as a consultant for the Food and Agriculture Organization of the UN and on the steering committee of OFFLU (OIE-FAO Network of Expertise for Animal Influenzas). Dr. Karesh is internationally recognized as an authority on the subject of animal and human health linkages and wildlife. He has published more than 160 scientific papers and numerous book chapters and written for broader audience publications such as Foreign Affairs and The Huffington Post.


Lawrence D. KERR, PhD

Lawrence Kerr is director, Pandemics and Emerging Threats, Office of Global Affairs, US Department of Health and Human Services. Prior to this, Dr. Kerr was director for Medical Preparedness Policy, National Security Staff, the White House. Dr. Kerr was the deputy director for Countering Biological Threats in the Office of the Director of National Intelligence (ODNI). He previously served as the senior bio advisor to the director of the National Counterproliferation Center (NCPC) in the ODNI. As a senior intelligence officer, Dr. Kerr advised the senior leadership on strategic plans to prevent and counter the spread of biological weapons of mass destruction in support of the National Intelligence Strategy. Before joining NCPC in April 2006, he was director for Biodefense Policy with the White House Homeland Security Council in the Executive Office of the President (EOP). He served as assistant director for Homeland Security for the Office of Science and Technology Policy (OSTP) and as director of Bioterrorism, Research and Development for the Office of Homeland Security in the EOP. Dr. Kerr joined the Life Sciences division of OSTP in January 2001, where he came from his position as chief of Transplantation, Transplantation and Immunology Branch, at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH).

Prior to his work at the NIH, Dr. Kerr worked in science and healthcare policy for Senator Orrin Hatch (R-UT) on the health subunit of the Senate Judiciary Committee during the 106th Congress. As a Robert Wood Johnson Fellow, he staffed the senator on a variety of legislative affairs, including NIH reauthorization; medical device coding for Medicare reimbursement; radiation exposure compensation litigation; interagency coordination of counter-bioterrorism efforts; traumatic brain injury act; pediatric AIDS; and Ryan White CARE reauthorization.

In his capacity at OSTP, Dr. Kerr advised the director in a variety of science and healthcare issues, including interagency coordination of chem/bio anti-terrorism technologies; infectious disease topics (HIV/AIDS, foot and mouth disease, etc.); cloning; embryonic and adult stem cell biology; and administered the Presidential Early Career Awards for Scientists and Engineers. As director of Bioterrorism, R&D, Dr. Kerr advised the assistant to the President for Homeland Security in identifying and fostering policies to meet national objectives. Dr. Kerr led and participated in the development of short- and long-range policies, including the president’s National Strategy on Homeland Security, the National Biodefense Strategy (HSPD-10), the Biosecurity Initiative, and, most recently, the National Strategy for Avian and Pandemic Influenza. He interfaced with senior officials and staffs of the White House, the Congress, the federal departments and agencies, and individuals from private industry and the academic community on counter-terrorism programs.

As an assistant professor in microbiology and immunology at Vanderbilt School of Medicine in Nashville, TN, Dr. Kerr ran a basic science laboratory devoted to the study of the transcriptional regulation of gene products involved in HIV replication and breast cancer development. He lectures at the national and international levels and has received awards for teaching excellence. He is the author of more than 50 peer-reviewed articles, reviews, and book chapters. He holds a BS in biology and art history from the University of the South in Sewanee, TN. Dr. Kerr completed his PhD in cell biology from Vanderbilt University in 1990 and undertook his postdoctoral work at the Salk Institute for Biological Studies in San Diego, CA. Dr. Kerr is currently an associate professor of microbiology and immunology at Georgetown University School of Medicine in Washington, DC.


Nai-Wen KUO, PhD, MPH

Nai-Wen Kuo was appointed as the dean of College of Public Health in August 01, 2016. Before then, he managed Taipei Medical University’s international affairs since October 2011. During his term as the dean of international affairs, he was responsible for all aspects of TMU International Office activities, which include foreign student recruitment, counseling and related services, international student and faculty exchanges, partner university relations and communications, international research collaborations, and medical mission operations.  

Dean Kuo joined the university in 1997 as a professor of health care administration. Before serving as dean of international affairs, he was appointed to many important positions within and beyond the university, including terms as TMU press director, as director of the School of Health Care Administration, as the university’s chief secretary, as advisor to Taipei City Hospital, and as chief surveyor for Hospital Accreditation, appointed by the Ministry of Health and Welfare.

Dean Kuo previously served as deputy chief executive officer of Taipei City Hospital, a 4,200-bed, 9-hospital system operated by the capital city’s government. His major responsibilities in this role included managing daily operations of a major hospital system, including quality improvement projects and financial analyses. Dean Kuo also served as vice superintendent of Taipei Medical University Hospital from 2000 to 2002. Under his management, this hospital turned a history of losses into its first profit-making year in 2002.

Dean Kuo is among Taiwan’s few healthcare administration educators who have held numerous leadership positions. He serves as a member of the board of directors of important academic societies including the Taiwan College of Healthcare Executives and the Taiwan Health Insurance Association. Dean Kuo’s research interests include healthcare quality, clinical pathways, patient safety, and healthcare facility design. Dean Kuo is the author of more than 50 publications, including journal articles, conference papers, and technical reports.

He received his PhD in health policy and management from Johns Hopkins University in 1997 and his MPH in health care administration in 1992 from Yale University. He was also a Fulbright Scholar at the University of Illinois at Urbana-Champaign in 2009 and 2010.


Steve Hsu-Sung KUO, MD, MPH, PHD

Steve Hsu-Sung Kuo was the former director-general, Centers for Disease Control, Ministry of Health and Welfare, ROC (Taiwan), until September 2016. Dr. Kuo held several positions at National Yang-Ming University, including associate professor, director of the Department of Social Medicine, and associate dean of the Faculty of Medicine. Dr. Kuo also served as senior advisor of the de facto Taiwan Embassy at the Taipei Economic and Cultural Representative Office (TECRO), representing the Ministry of Health, Taiwan.

Dr. Kuo received his medical degree from National Yang-Ming Medical College, his master’s of public health from National Taiwan University, and his PhD in health policy from Yale University.


Philip Yi-Chun LO, MD

Philip Yi-Chun Lo is deputy director-general, Centers for Disease Control, Ministry of Health and Welfare, Taiwan. Prior to this, he was director, Office of Preventive Medicine, Centers for Disease Control, Ministry of Health, Taiwan, and director, Field Epidemiology Training Program, Centers for Disease Control, Ministry of Health, Taiwan. Dr. Lo is also an adjunct attending physician, Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital.

He received his MD from National Taiwan University College of Medicine, Taipei, Taiwan. He is trained in internal medicine and clinical infectious diseases.



Maria Julia Marinissen is the director of the Division of International Health Security in the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). She represents HHS and ASPR in several White House National Security Council interagency policy committees and in several multilateral partnerships on global health security. Since 2009, she has been the US liaison to the Global Health Security Initiative (GHSI), a ministerial-level effort of the G7 countries, Mexico, the European Commission, and the World Health Organization (WHO). She was founder of and currently chairs the North American Health Security Working Group, which developed the North American Plan for Animal and Pandemic Influenza launched by the leaders of the United States, Mexico, and Canada in 2012.

Her division leads the development and implementation of frameworks for international response policy coordination and mutual assistance, including laboratory samples, medical countermeasures, and medical personnel sharing during public health emergencies. She led the US donation of antivirals and vaccines to WHO and foreign countries during the H1N1 (2009) pandemic. She also supervises the US International Health Regulations (IHR) program, which manages the US IHR National Focal Point and monitors US compliance with the WHO’s IHR framework. In 2016, she and her team led a comprehensive, multidisciplinary assessment of US health security capacities as defined by the Global Health Security Agenda (GHSA) and the IHR using the Joint External Evaluation (JEE) methodology. In addition, she oversees IHR capacity-building programs for surveillance, early-warning infectious disease surveillance, laboratory diagnostics, emergency communications, and IHR NFP strengthening in partner countries in Latin America, Africa, and Southeast Asia.

In 2006, she joined ASPR as a science and technology policy fellow sponsored by the American Association for the Advancement of Science. She graduated from the Annenberg Leadership Institute in 2009 and Harvard’s National Preparedness Leadership Initiative in 2014. Prior to her career in policy, Dr. Marinissen was a “Ramon y Cajal” investigator at the Universidad Autonoma de Madrid (2004-2006) and a postdoctoral fellow and senior researcher at the National Institutes of Health (1997-2003). She completed both her PhD and master’s degree in biology at the Universidad Nacional del Sur in Bahia Blanca, Argentina.


Jennifer NUZZO, DrPH

Jennifer Nuzzo is a senior associate at the UPMC Center for Health Security and an associate in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. An epidemiologist by training, her work focuses on international and domestic biosurveillance, infectious disease diagnostics, and disease mitigation strategies. She also has worked on issues related to the Affordable Care Act, tuberculosis control, foodborne outbreaks, and water security. Dr. Nuzzo is an associate editor of the peer-reviewed journal Health Security (formerly Biosecurity and Bioterrorism), and she was co-managing editor of the Biosecurity Briefing, a weekly internet-based news, science, and policy update.

In addition to her work at the Center, Dr. Nuzzo has advised national governments and nonprofit organizations. She has served as a consultant to the National Biosurveillance Advisory Subcommittee, as a member of the US Environmental Protection Agency’s National Drinking Water Advisory Council (NDWAC), and as a member of the NDWAC’s Water Security Working Group. She has also served as a project advisor for the American Water Works Association Research Foundation (now called the Water Research Foundation), a primary funding organization for drinking water research in the United States. She has been consulted on pandemic planning efforts in the Republic of Indonesia and Taiwan.

Dr. Nuzzo joined the Center at its founding in 2003, and she has served as an analyst, senior analyst, and associate. Prior to joining the Center, she served as a research analyst with the Center for Civilian Biodefense Strategies at the Johns Hopkins Bloomberg School of Public Health.

In 2002 and 2003, Dr. Nuzzo worked as a public health epidemiologist for the City of New York, where she was involved with disease and syndromic surveillance efforts related to the city’s Waterborne Disease Risk Assessment Program. Central to her duties in New York was the management of the city’s drug sale monitoring program for surveillance of diarrheal illness. She also worked on a local climate change initiative for the city of Cambridge, MA.

Dr. Nuzzo received a DrPH in epidemiology from the Johns Hopkins Bloomberg School of Public Health, an SM in environmental health from Harvard University, and a BS in environmental sciences from Rutgers University.


Theresa L. SMITH, MD, MPH

Theresa L. Smith received her doctor of medicine degree from the University of Iowa and her master’s in public health from Johns Hopkins University. She is board certified in internal medicine, infectious diseases, and general preventive medicine. She joined the Centers for Disease Control and Prevention in 1997 as an Epidemic Intelligence Service officer in the Hospital Infections Program, developed expertise in surveillance with the Division of HIV and AIDS Prevention, and in bacterial zoonoses with the Division of Vector-borne Infectious Diseases. Dr. Smith began working in medical countermeasures and preparedness in the Bacterial Special Pathogens Branch, where she was branch chief. In 2012, she joined the National Security Council as director of medical preparedness policy for the White House. She is currently the associate director for science for CDCs Office of Public Health Preparedness and Response Division of State and Local Readiness.



Eric Toner is a senior associate with the UPMC Center for Health Security. He is an internist and emergency physician. His primary areas of interest are healthcare preparedness for catastrophic events, pandemic influenza, and medical response to bioterrorism. He is managing editor of the online newsletter Clinicians’ Biosecurity News and is an associate editor of the journal Health Security (formerly Biosecurity and Bioterrorism), the leading peer-reviewed journal in this field.

Dr. Toner has authored scores of scholarly papers and government reports on healthcare and pandemic preparedness, and he has organized numerous meetings of national leaders on the topics of hospital preparedness, pandemic influenza, emerging infectious diseases, mass casualty disasters, biosecurity, biosurveillance, and nuclear preparedness. He has spoken at many national and international conferences on a range of biosecurity topics and appeared on a number of high-profile national television and news features on pandemic flu and bioterrorism preparedness. He has been the principal investigator of several US government–funded projects to assess and advance healthcare preparedness. Dr. Toner has served on a number of national working groups and committees, including the Institute of Medicine’s Forum on Medical and Public Health Preparedness for Catastrophic Events.

Dr. Toner has been involved in hospital disaster planning since the mid-1980s. Prior to joining the Center, he was medical director of disaster preparedness at St. Joseph Medical Center in Towson, Maryland, where he practiced emergency medicine for 23 years. In 2003, he spearheaded the creation of a coalition of disaster preparedness personnel from the 5 Baltimore County hospitals, the health department, and the Office of Emergency Management. During this time, he also headed a large emergency medicine group practice and co-founded and managed a large primary care group practice and an independent urgent care center.

Dr. Toner received his BA and MD degrees from the University of Virginia. He trained in internal medicine at the Medical College of Virginia.


Ji-Rong YANG, MSc

Ji-Rong Yang is a technical specialist, Laboratory of Viral Respiratory Diseases, Center for Research, Diagnostics and Vaccine Development, Taiwan Centers for Disease Control. Mr. Yang has also been a specialist and assistant researcher at the Viral Respiratory Diseases, Center for Research, Diagnostics and Vaccine Development, Taiwan Centers for Disease Control.

Mr. Yang is a PhD candidate at the National Taiwan Universtiy, Taiwan, Institute of Biotechnology and has a master of science degree from National Yang-Ming University, Tawain, Institute of Genetics.



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.